FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to the use of a monoclonal antibody against claudin 1. A pharmaceutical composition is disclosed, containing effective amount of the specified monoclonal antibody.
EFFECT: invention allows for the effective treatment of liver diseases that are not associated with HCV.
12 cl, 16 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2540490C2 |
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2478400C2 |
| RECOMBINANT VECTORS BASED ON 'LIVE' VIRUS OF FOWL POX AND THEIR APPLICATION IN PHARMACEUTICAL COMPOSITIONS AGAINST VIRUS OF HEPATITIS C | 2005 |
|
RU2353651C2 |
| ANTIBODIES SPECIFIC TO BTN2 AND THEIR APPLICATIONS | 2018 |
|
RU2794996C2 |
| ALLOSTERIC ANTIBODIES AGAINST HUMAN HER3 NON COMPETITIVE FOR NEUREGULIN AND USE THEREOF | 2013 |
|
RU2704228C2 |
| BTN2-SPECIFIC ANTIBODIES AND USE THEREOF | 2020 |
|
RU2821703C2 |
| COMPOSITION FOR PREVENTING AND/OR TREATING INFECTION, CAUSED BY HIV-1 | 2012 |
|
RU2603262C2 |
| ANTIBODIES TO BTN3A AND THEIR USE IN THE TREATMENT OF CANCER OR INFECTIOUS DISEASES | 2019 |
|
RU2800726C2 |
| VACCINE COMPOSITION POTENTIATED WITH DNA AND ANTIGEN COMBINATION | 2002 |
|
RU2294212C2 |
| VACCINES AGAINST HEPATITIS VIRUSES | 1995 |
|
RU2189254C2 |
